Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

After years of striking acquisitions to build up its site network, Headlands Research has now been bought itself.  | After ...

Lakeshore Bone and Joint Institute has been selected as one of the 45 U.S. sites for a new clinical study evaluating the use of mesenchymal precursor cells (a type of stem cells) in subjects with ...